Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- Check4 days agoChange DetectedLocations section updated with new state entries and the version tag changed to v3.3.3. The previous state locations and the HHS Vulnerability Disclosure text were removed.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedA government funding notice about potential data updates was removed from the page. The study details and navigation remain unchanged.SummaryDifference0.3%

- Check54 days agoChange DetectedNo significant changes were identified in the study record; core details such as title, NCT number, conditions, interventions, endpoints, and locations remain unchanged, with only minor visual/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference4%

- Check90 days agoChange DetectedPage version updated to v3.1.0; one term “Early myoclonic encephalopathy” removed.SummaryDifference0.2%

Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.